In the Senate of the United States, 

December 1, 2022. 

Resolved, That the bill from the House of Representatives (H.R. 1193) entitled ‘‘An Act to amend title IV of the 

Public Health Service Act to direct the Director of the National Institutes of Health, in consultation with the Director 

of the National Heart, Lung, and Blood Institute, to establish a program under which the Director of the National Institutes of Health shall support or conduct research on valvular heart disease, and for other purposes.’’, do pass with 

the following 

AMENDMENT: 

Strike all after the enacting clause and insert the 

following: 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Cardiovascular Ad3 vances in Research and Opportunities Legacy Act’’. 

4 SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. 

5 (a) IN GENERAL.—The Secretary of Health and 

6 Human Services (referred to in this section as the ‘‘Sec-
2 

† HR 1193 EAS 

1 retary’’) shall, as appropriate, continue activities related 

2 to research, education, and awareness of valvular heart dis3 eases. 

4 (b) NIH RESEARCH RELATED TO VALVULAR HEART

5 DISEASES.— 

6 (1) IN GENERAL.—The Director of the National 

7 Institutes of Health, in consultation with the Director 

8 of the National Heart, Lung, and Blood Institute, 

9 may support or conduct research regarding valvular 

10 heart diseases. 

11 (2) SUPPORT FURTHER RESEARCH.—In order to 

12 improve information on, and understanding of, cau13 sation and risk factors for valvular heart diseases, re14 search conducted or supported under this subsection 

15 for such diseases may include the following: 

16 (A) Use of advanced technological imaging 

17 and other relevant methods to generate data re18 lated to valvular heart diseases. 

19 (B) Assessing potential risk factors for sud20 den cardiac arrest or sudden cardiac death from 

21 valvular heart diseases. 

22 (C) Other activities, as appropriate, in 

23 order to improve the availability of information 

24 on, and advance research related to, valvular 

25 heart diseases. 
3 

† HR 1193 EAS 

1 (3) MITRAL VALVE PROLAPSE WORKSHOP.—Not 

2 later than 2 years after the date of enactment of this 

3 Act, the Director of the National Heart, Lung, and 

4 Blood Institute shall, as appropriate, convene a work5 shop composed of subject matter experts and stake6 holders to identify research needs and opportunities to 

7 develop recommendations for the identification and 

8 treatment of individuals with mitral valve prolapse, 

9 including such individuals who may be at risk for 

10 sudden cardiac arrest or sudden cardiac death. 

11 (c) PREVENTION ACTIVITIES TO IMPROVE AWARENESS

12 OF SUDDEN CARDIAC DEATH AS A RESULT OF VALVULAR

13 HEART DISEASES.— 

14 (1) IN GENERAL.—The Secretary may carry out 

15 activities to increase education and awareness of val16 vular heart diseases in order to reduce the incidence 

17 of sudden cardiac death caused by such diseases. The 

18 Secretary may— 

19 (A) award grants or contracts to public or 

20 nonprofit private entities to carry out activities 

21 under this subsection; and 

22 (B) directly, or through grants or contracts, 

23 provide technical assistance with respect to such 

24 activities. 
4 

† HR 1193 EAS 

1 (2) CERTAIN ACTIVITIES.—Upon availability of 

2 applicable data, projects carried out under paragraph 

3 (1) may include— 

4 (A) continuing activities at the Centers for 

5 Disease Control and Prevention related to val6 vular heart diseases; 

7 (B) improving the awareness of the public 

8 concerning any risk factors for, the symptoms of, 

9 and the public health impact of, valvular heart 

10 diseases; and 

11 (C) enhancing public health data collection 

12 and improving the quality of such data, as ap13 propriate, regarding cardiac arrests, including 

14 cardiac arrests that occur outside of the hospital. 

15 (3) GRANT PRIORITIZATION.—The Secretary 

16 may, in awarding grants or entering into contracts 

17 pursuant to paragraph (1), give priority to entities 

18 seeking to carry out projects for populations most im19 pacted by valvular heart diseases. 

20 (4) COORDINATION OF ACTIVITIES.—The Sec21 retary shall, as appropriate, ensure that activities 

22 under this section are coordinated with other agencies 

23 and offices of the Department of Health and Human 

24 Services that carry out activities regarding valvular 

25 heart diseases. 
5 

† HR 1193 EAS 

1 (5) BEST PRACTICES.—The Secretary shall, as 

2 applicable and appropriate, identify and disseminate 

3 best practices for relevant health care providers re4 lated to valvular heart diseases. 

5 (d) AUTHORIZATION OF APPROPRIATIONS.—For pur6 poses of carrying out this section, there are authorized to 

7 be appropriated $28,000,000 for each of fiscal years 2023 

8 through 2027. 

Attest: 

Secretary. 
117TH CONGRESS 

2D SESSION H.R. 1193 

AMENDMENT